These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 652121)

  • 1. Drug-induced changes of brain serotoninergic tone and insulin-induced growth hormone release in the dog.
    Locatelli V; Panerai AE; Cocchi D; Gil-Ad I; Mantegazza P; Secchi C; Müller EE
    Neuroendocrinology; 1978; 25(2):84-104. PubMed ID: 652121
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphine acts through alpha adrenergic and serotoninergic neurons to stimulate growth hormone secretion in the dog.
    Farris TS; Richards GE
    Life Sci; 1980 Oct; 27(14):1345-9. PubMed ID: 6255275
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of hypoglycemia-induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide.
    Bivens CH; Lebovitz HE; Feldman JM
    N Engl J Med; 1973 Aug; 289(5):236-9. PubMed ID: 4713762
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of 5-hydroxytryptophan on prolactin and growth hormone release in the infant rat: evidence for different neurotransmitter mediation.
    Cocchi D; Gil-Ad I; Panerai AE; Locatelli V; Müller EE
    Neuroendocrinology; 1977; 24(1):1-13. PubMed ID: 23503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of antiserotonergic agents on the action of dopaminergic drugs.
    Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
    Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats.
    Fuller RW; Snoddy HD
    Endocrinology; 1979 Oct; 105(4):923-8. PubMed ID: 477605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine profile and therapeutic employment of a new prolactin-lowering drug, metergoline.
    Ferrari C; Reschini E; Peracchi M; Crosignani PG
    Gynecol Obstet Invest; 1980; 11(1):1-16. PubMed ID: 6248438
    [No Abstract]   [Full Text] [Related]  

  • 8. Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats.
    Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F
    Eur J Pharmacol; 1980 Jan; 61(2):203-6. PubMed ID: 7353591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the cholinergic system and growth hormone release in the dog: functional interactions with other neurotransmitters.
    Betti R; Casanueva FF; Cella SG; Müller EE
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):36-43. PubMed ID: 2982238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metergoline and other peripheral serotonin antagonists inhibit prolactin secretion through mechanisms unrelated to serotonin.
    Lamberts SW; MacLeod RM
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):75-9. PubMed ID: 504241
    [No Abstract]   [Full Text] [Related]  

  • 11. Some aspects of the dopaminergic action of ergot derivatives and their role in the treatment of migraine.
    Horowski R
    Adv Neurol; 1982; 33():325-34. PubMed ID: 7055013
    [No Abstract]   [Full Text] [Related]  

  • 12. D-Fenfluramine and D-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain.
    Borsini F; Bendotti C; Aleotti A; Samanin R; Garattini S
    Pharmacol Res Commun; 1982 Jul; 14(7):671-8. PubMed ID: 6215652
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolactin suppression by serotonin antagonists in man: further evidence for serotoninergic control of prolactin secretion.
    Ferrari C; Caldara R; Romussi M; Rampini P; Telloli P; Zaatar S; Curtarelli G
    Neuroendocrinology; 1978; 25(6):319-28. PubMed ID: 662080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collateral inhibition of serotonergic neurones in the rat dorsal raphe nucleus: pharmacological evidence.
    Wang RY; Aghajanian GK
    Neuropharmacology; 1978 Oct; 17(10):819-25. PubMed ID: 154620
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites.
    Blackshear MA; Friedman RL; Sanders-Bush E
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):125-9. PubMed ID: 6646240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of several serotonin receptor antagonists on basal and stimulus induced release of insulin and glucagon in the intact rat.
    Bryce GF; Jacoby JH
    Life Sci; 1978 Jun; 22(24):2215-23. PubMed ID: 353424
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of human growth hormone secretion by melatonin and cyproheptadine.
    Smythe GA; Lazarus L
    J Clin Invest; 1974 Jul; 54(1):116-21. PubMed ID: 4600047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of serotonin and its antagonists on the first phase of insulin release in normal and hypersomatotropic rats.
    de Bold ML; Bencosme SA
    Horm Metab Res; 1978 Nov; 10(6):500-5. PubMed ID: 744569
    [No Abstract]   [Full Text] [Related]  

  • 20. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R; Miranda GF; Verry M
    Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.